Nodularis Prurigo
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis (NCT02174432) | Trevi Therapeutics | 2015-08-15 |
| Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis (NCT02174419) | Trevi Therapeutics | 2015-03-01 |
Track Nodularis Prurigo automatically
Every clearance here is in the API, with alerts when new ones post.